
Forums moderator DeAnn Runge shares her experience of getting Spinraza amidst the COVID pandemic.
SMA News Today’s multimedia associate, Price Wooldridge, discusses how Risdiplam defies SMA “natural history” in type 1 infants, according to FIREFISH study data.
Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/